AU2015278962B2 - Thioureylene liquid compositions - Google Patents

Thioureylene liquid compositions Download PDF

Info

Publication number
AU2015278962B2
AU2015278962B2 AU2015278962A AU2015278962A AU2015278962B2 AU 2015278962 B2 AU2015278962 B2 AU 2015278962B2 AU 2015278962 A AU2015278962 A AU 2015278962A AU 2015278962 A AU2015278962 A AU 2015278962A AU 2015278962 B2 AU2015278962 B2 AU 2015278962B2
Authority
AU
Australia
Prior art keywords
composition according
composition
polysaccharide
group
combinations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2015278962A
Other languages
English (en)
Other versions
AU2015278962A1 (en
Inventor
Louise Reynolds
Manish UMRETHIA
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Norbrook Licences Ltd
Original Assignee
Norbrook Licences Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norbrook Licences Ltd filed Critical Norbrook Licences Ltd
Publication of AU2015278962A1 publication Critical patent/AU2015278962A1/en
Application granted granted Critical
Publication of AU2015278962B2 publication Critical patent/AU2015278962B2/en
Assigned to NORBROOK LICENCES LIMITED reassignment NORBROOK LICENCES LIMITED Request for Assignment Assignors: NORBROOK LABORATORIES LIMITED
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A61P5/16—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4 for decreasing, blocking or antagonising the activity of the thyroid hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Physiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nutrition Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2015278962A 2014-06-25 2015-06-23 Thioureylene liquid compositions Active AU2015278962B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1411310.4 2014-06-25
GB1411310.4A GB2527555B (en) 2014-06-25 2014-06-25 Stable methimazole liquid compositions
PCT/GB2015/051824 WO2015198033A1 (en) 2014-06-25 2015-06-23 Thioureylene liquid compositions

Publications (2)

Publication Number Publication Date
AU2015278962A1 AU2015278962A1 (en) 2016-12-22
AU2015278962B2 true AU2015278962B2 (en) 2019-07-04

Family

ID=51410113

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2015278962A Active AU2015278962B2 (en) 2014-06-25 2015-06-23 Thioureylene liquid compositions

Country Status (19)

Country Link
US (6) US10045967B2 (enExample)
EP (2) EP3160441B1 (enExample)
JP (1) JP6799465B2 (enExample)
AU (1) AU2015278962B2 (enExample)
CA (1) CA2952336C (enExample)
CY (2) CY1124535T1 (enExample)
DK (2) DK3160441T3 (enExample)
ES (2) ES2905083T3 (enExample)
GB (1) GB2527555B (enExample)
HR (2) HRP20220078T1 (enExample)
HU (1) HUE056787T2 (enExample)
LT (2) LT3160441T (enExample)
NZ (1) NZ728018A (enExample)
PL (2) PL3160441T3 (enExample)
PT (2) PT3441063T (enExample)
RS (2) RS62850B1 (enExample)
SI (2) SI3441063T1 (enExample)
SM (2) SMT202200043T1 (enExample)
WO (1) WO2015198033A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2527555B (en) 2014-06-25 2018-09-19 Norbrook Lab Ltd Stable methimazole liquid compositions
GB2702386A (en) * 2024-11-22 2026-06-10 Liqmeds Worldwide Ltd An oral non-aqueous solution of carbimazole

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4096174A (en) * 1977-07-01 1978-06-20 American Cyanamid Company Anionic naphthalene thioureido-diphenyloxides
DE3013839A1 (de) * 1979-04-13 1980-10-30 Freunt Ind Co Ltd Verfahren zur herstellung einer aktivierten pharmazeutischen zusammensetzung
US5310742A (en) * 1992-11-30 1994-05-10 Elias Alan N Uses for thioureylenes
WO2007087623A2 (en) * 2006-01-26 2007-08-02 Hill's Pet Nutrition, Inc. Methods and compositions for treating feline hyperthyroidism

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001257511A1 (en) * 2000-05-03 2001-11-12 Joe D'silva Process and device for producing liquid dosage formulations
US20050158367A1 (en) * 2004-01-16 2005-07-21 The Procter & Gamble Company Liquid compositions comprising one or more medicaments
GB2438287A (en) * 2006-05-19 2007-11-21 Norbrook Lab Ltd Stable aqueous suspension
CA2703008A1 (en) * 2007-11-15 2009-05-22 Novartis Ag Anthelmintic paste comprising praziquantel, a macrolide lactone, cyclodextrin and a thickener
GB2527555B (en) 2014-06-25 2018-09-19 Norbrook Lab Ltd Stable methimazole liquid compositions

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4096174A (en) * 1977-07-01 1978-06-20 American Cyanamid Company Anionic naphthalene thioureido-diphenyloxides
DE3013839A1 (de) * 1979-04-13 1980-10-30 Freunt Ind Co Ltd Verfahren zur herstellung einer aktivierten pharmazeutischen zusammensetzung
US5310742A (en) * 1992-11-30 1994-05-10 Elias Alan N Uses for thioureylenes
WO2007087623A2 (en) * 2006-01-26 2007-08-02 Hill's Pet Nutrition, Inc. Methods and compositions for treating feline hyperthyroidism

Also Published As

Publication number Publication date
CA2952336A1 (en) 2015-12-30
US20250064785A1 (en) 2025-02-27
US20180318262A1 (en) 2018-11-08
EP3441063A1 (en) 2019-02-13
CY1124535T1 (el) 2022-07-22
HUE056787T2 (hu) 2022-03-28
US20170135987A1 (en) 2017-05-18
LT3441063T (lt) 2021-10-11
RS62850B1 (sr) 2022-02-28
AU2015278962A1 (en) 2016-12-22
SMT202200043T1 (it) 2022-03-21
CA2952336C (en) 2023-02-14
RS62321B1 (sr) 2021-10-29
GB2527555B (en) 2018-09-19
HRP20211354T1 (hr) 2021-11-26
GB2527555A (en) 2015-12-30
PT3160441T (pt) 2022-01-28
PL3441063T3 (pl) 2021-12-27
US11738005B2 (en) 2023-08-29
PL3160441T3 (pl) 2022-02-28
HRP20220078T1 (hr) 2022-04-15
JP6799465B2 (ja) 2020-12-16
CY1124961T1 (el) 2023-01-05
HRP20211354T8 (hr) 2022-03-04
US11123327B2 (en) 2021-09-21
JP2017519029A (ja) 2017-07-13
US20210361623A1 (en) 2021-11-25
US20200405690A1 (en) 2020-12-31
ES2905083T3 (es) 2022-04-19
DK3160441T3 (da) 2022-01-31
SMT202100487T1 (it) 2021-09-14
EP3160441A1 (en) 2017-05-03
NZ728018A (en) 2019-06-28
DK3441063T3 (da) 2021-08-30
PT3441063T (pt) 2021-08-31
ES2884573T3 (es) 2021-12-10
WO2015198033A1 (en) 2015-12-30
EP3160441B1 (en) 2022-01-12
US10045967B2 (en) 2018-08-14
EP3441063B1 (en) 2021-07-21
LT3160441T (lt) 2022-02-25
SI3160441T1 (sl) 2022-04-29
SI3441063T1 (sl) 2021-12-31
US12171749B2 (en) 2024-12-24
US20230404978A1 (en) 2023-12-21
GB201411310D0 (en) 2014-08-06

Similar Documents

Publication Publication Date Title
US20250064785A1 (en) Thioureylene liquid compositions
TWI920454B (zh) 包含5-膽甾烯-3,25-二醇3-硫酸酯(25hc3s)或其醫藥上可接受之鹽及至少一種環狀寡醣的組成物,以及使用彼等之方法
US20130095146A1 (en) Ciclesonide containing aqueous pharmaceutical composition
US20240374516A1 (en) Ready to use oral pharmaceutical suspension of dasatinib
MX2014010274A (es) Composiciones de liberacion controlada y metodos para su uso.
EA022936B1 (ru) Стабильные водосодержащие препараты, включающие плохо растворимые в воде активные компоненты
US11576929B2 (en) Composition for inflammatory gastrointestinal disorders
EP3402526B1 (en) New improved composition comprising at least one cadotril
HK40084620A (en) Compositions comprising 5-cholesten-3, 25-diol, 3-sulfate (25hc3s) or pharmaceutically acceptable salt thereof and at least one cyclic oligosaccharide

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
PC Assignment registered

Owner name: NORBROOK LICENCES LIMITED

Free format text: FORMER OWNER(S): NORBROOK LABORATORIES LIMITED